Section Arrow
Quote
CRL.NYSE
- Charles River Laboratories International
Quotes are at least 15-min delayed:2025/07/03 03:52 EDT
Last
 157.49
+3.09 (+2.00%)
Day High 
158.38 
Prev. Close
154.4 
1-M High
160.4037 
Volume 
637.21K 
Bid
--
Ask
--
Day Low
152.84 
Open
154.01 
1-M Low
132.5828 
Market Cap 
7.58B 
Currency USD 
P/E 706.8 
%Yield -- 
10-SMA 149.15 
20-SMA 148.05 
50-SMA 136.6 
52-W High 254.15 
52-W Low 91.8609 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.61/9.83
Enterprise Value
10.31B
Balance Sheet
Book Value Per Share
65.04
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
4.05B
Operating Revenue Per Share
85.83
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.23+0.15+2.95%879PE
BIAFbioAffinity Technologies0.29+0.0265+10.06%-- 
DHRDanaher Corp202.5+1.4+0.70%38.97PE
OPKOPKO Health1.34+0.01+0.75%-- 
TMOThermo Fisher Scientific427.76+6.29+1.49%24.72PE
Quotes are at least 15-min delayed：2025/07/03 03:52 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.